key: cord-0031337-ymk0nsrh
authors: Marco, Rossato; Angelo, Di Vincenzo
title: Commentary to the paper: Association of smoking and severity of covid-19 infection among 5889 patients in malaysia: a multi-centre observational study, by Ismail N, Hassan N, Hamid MHNA, Yusoff UN, Khamal NR, Omar MA, et al. published in Int J Infect Dis. 2022;116:189-96.
date: 2022-05-13
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2022.05.015
sha: 85eaf2361e0cb187df5c91b37b1519d67c96223e
doc_id: 31337
cord_uid: ymk0nsrh

nan

Dear Editor, we have read with interest the paper by Ismail et al. reporting data on the severity of COVID-19 in smokers with respet to never smokers in a large group of hospitalized COVID-19 patients (Ismail et al., 2022) .

All studies published so far have reported a very low prevalence of active smokers among hospitalized patients for COVID-19 (Farsalinos et al., 2020; Lee et al., 2021; Miyara et al., 2020; Rossato et al., 2020) These observations lead to hypothesize a sort of "protective" effect of some component of cigarette smoking, possibly nicotine, mainly on severe respiratory complications of COVID-19 leading to ARDS. To this respect also the Authors in their study reported a low prevalence of current smokers among hospitalized patients for COVID-19 (9% of current smokers and 91% of non active smokers, i.e. former or never smokers) (Ismail et al., 2022) although they did not fully exploit this result in their paper.

One major problem in their paper is that the Authors considered active smokers and former smokers as a whole and this could have modified their results. To this respect in a sub-analysis the Authors reported a higher prevalence of kidney and liver injury in former smokers than in current smokers explaining this with a supposed longer smoking history in former than in current smokers, an explanation not supported by the demographic data reported in the paper.

Furthermore, to support the negative effects of cigarette smoking on COVID-19 outcomes, the Authors have cited a reference dealing with the role of nicotine in inflammation but that referenced paper reported that nicotine exerts anti-inflammatory effects and evidence has been reported that active smokers and nicotine have a lower incidence of different inflammatory diseases (Kalra et al., 2004; Piao et al., 2019; Sopori et al., 1998) .

Finally, the report that ever smokers have higher proportion of severe oucomes is somehow misleading, since these observations were not statistically significant as stated by the Authors.

Obviously, the supposed "protective" effects of cigarette smoking (nicotine?) on SARS-CoV-2 related complications leading to hospitalization has not to push smoking addiction but on the contrary cigarette smoking has to be blamed for its well known unhealthy effects.

These observations have to push researchers to investigate the reason for such putative "protective" effects. The conclusions of the Authors seem to address to the opposite direction, despite their observations that current smokers are quite low among hospitalized COVID-19 patients.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Farsalinos K, Barbouni A, Niaura R. Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med. 2020;15:845-52.

Association of smoking and severity of covid-19 infection among 5889 patients in Malaysia: a multicentre observational study

Smoking and the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection

Low rate of daily active tobacco smoking in patients with symptomatic COVID-19

Nicotine and inflammatory neurological disorders

Current smoking is not associated with COVID-19

Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms